Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Adopting a 30th birthday genetic profile test could save lives and NHS costs

A new study published in the US medical journal ‘The Annals of Internal Medicine’ makes a very strong case for universal genetic testing at the age of 30.

24 Jun 2023

3D models of ovarian cancer reveal how cell’s location can affect tumor biology

Using 3-D models of ovarian cancer tumors, scientists found differences in gene activity based on where a cell is in a tumor, demonstrating how a cell's location and environment in a cancerous tumor can strongly influence which genes are active and the cell's role in the cancer's biology.

23 Jun 2023

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.

21 Jun 2023

Early-career scientists chosen for 2023 class of the Pew-Stewart Scholars Program for Cancer Research

The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2023 class of the Pew-Stewart Scholars Program for Cancer Research.

13 Jun 2023

Women's use of contraceptive pills linked to greater risk of depression

Women who used combined contraceptive pills were at greater risk of developing depression than women who did not, according to a new study from Uppsala University. Contraceptive pills increased women's risk by 73 per cent during the first two years of use.

12 Jun 2023

Study shows efficacy and safety of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

Updated dose expansion data of the phase I STRO-002-GM1 study have been presented today by Ana Oaknin, Principal Investigator of the Vall d'Hebron Institute of Oncology's (VHIO) Gynecological Malignancies Group, on the ground at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO), 2-6 June in Chicago, USA.

4 Jun 2023

NCI launches new initiative to test new drug combinations that target specific tumor alterations

The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations.

1 Jun 2023

New understanding of chemotherapeutic resistance in recurring ovarian cancer

A new editorial paper was published in Oncoscience (Volume 10) on May 11, 2023, entitled, "UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?"

26 May 2023

Scientists to discuss the latest cancer therapies, advances in PSMA PET scans and many more at ASCO

Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology's annual meeting.

23 May 2023

Research findings bring order to the genomic chaos of ovarian high grade serous carcinoma

New research findings based on the evolution of malignant tumors increase our understanding of the characteristics of an ovarian cancer subtype that is difficult to treat.

19 May 2023

Study establishes a mechanistic link between obesity and oral cancer immune escape

A team from the University of Michigan Rogel Cancer Center and School of Dentistry, led by Yu Leo Lei, D.D.S., Ph.D., have identified a mechanism in mice for how obesity affects some oral cancers' ability to escape from the immune system.

16 May 2023

Break Through Cancer funds AML research at MD Anderson

The University of Texas MD Anderson Cancer Center was awarded more than $5.7 million in grants from Break Through Cancer to support collaborative research teams working to discover novel molecular targets to eradicate minimal residual disease in acute myeloid leukemia (AML) and to treat clonal hematopoiesis, a precursor to AML.

16 May 2023

Maintaining a healthy weight could reduce future gastrointestinal cancer risk

Doctors have long stressed the importance of maintaining a healthy weight for improving overall health, but a large new study also suggests it could also reduce future gastrointestinal cancer (GI) risk.

10 May 2023

Study reports cost-effectiveness of population genetic testing

An exhaustive cost-benefit analysis of population genetic testing published in Annals of Internal Medicine concludes with a recommendation to U.S. health policymakers to adopt routine testing of adults ages 40 and under for three genetic conditions posing high risk of life-threatening illness.

9 May 2023

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Adopting a 30th birthday genetic profile test could save lives and NHS costs

3D models of ovarian cancer reveal how cell’s location can affect tumor biology

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

Early-career scientists chosen for 2023 class of the Pew-Stewart Scholars Program for Cancer Research

Women's use of contraceptive pills linked to greater risk of depression

Study shows efficacy and safety of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

NCI launches new initiative to test new drug combinations that target specific tumor alterations

New understanding of chemotherapeutic resistance in recurring ovarian cancer

Scientists to discuss the latest cancer therapies, advances in PSMA PET scans and many more at ASCO

Research findings bring order to the genomic chaos of ovarian high grade serous carcinoma

Study establishes a mechanistic link between obesity and oral cancer immune escape

Break Through Cancer funds AML research at MD Anderson

Maintaining a healthy weight could reduce future gastrointestinal cancer risk

Study reports cost-effectiveness of population genetic testing

HIPEC: A promising treatment for certain patients with Stage IV abdominal cancer

Point-of-care testing can be effective for improving access to cancer genetic services

New class of immunotherapy shows promise against aggressive skin cancer

SWOG investigators report results from DART clinical trial of immunotherapy combination for rare gynecologic cancers

Endometriosis linked to increased risk of cardiovascular disease in women

Elucidating the function of BRCA2 gene offers insight into cancer development

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in